Regenerative medicine in kidney disease

Kidney International

Volumn 90, Issue 2, 2016, Pages 289-299

  Little, Melissa H ^a,b   Kairath, Pamela ^a,b  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

directed differentiation; kidney development; kidney organoid; kidney repair; progenitor; regeneration; stem cell

Indexed keywords

ACUTE KIDNEY FAILURE; CELL POPULATION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CHRONIC KIDNEY FAILURE; DISEASE COURSE; HUMAN; INDUCED PLURIPOTENT STEM CELL; KIDNEY REGENERATION; KIDNEY TUBULE CELL; MACROPHAGE; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; REGENERATION; REGENERATIVE MEDICINE; REPERFUSION INJURY; REVIEW; ANIMAL; BIOLOGICAL THERAPY; CYTOLOGY; FETAL STEM CELL; KIDNEY; KIDNEY DISEASES; MESENCHYMAL STROMA CELL; PHYSIOLOGY; PROCEDURES; STEM CELL TRANSPLANTATION; WOUND HEALING;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; CELLULAR REPROGRAMMING; FETAL STEM CELLS; HUMANS; KIDNEY; KIDNEY DISEASES; MESENCHYMAL STROMAL CELLS; REGENERATION; STEM CELL TRANSPLANTATION; WOUND HEALING;

EID: 84992513869     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.03.030     Document Type: Review

References (119)

1. 1 Little, M.H., Regrow or repair: potential regenerative therapies for the kidney. J Am Soc Nephrol 17 (2006), 2390–2401.
2. 2 Witzgall, R., Brown, D., Schwarz, C., Bonventre, J.V., Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney: evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93 (1994), 2175–2188.
3. 3 Hinchliffe, S.A., Sargent, P.H., Howard, C.V., et al. Human intrauterine renal growth expressed in absolute number of glomeruli assessed by the disector method and Cavalieri principle. Lab Invest 64 (1991), 777–784.
4. 4 Hewitson, T.D., Ono, T., Becker, G.J., Small animal models of kidney disease: a review. Methods Mol Biol 466 (2009), 41–57.
5. 5 Cochrane, A.L., Kett, M.M., Samuel, C.S., et al. Renal structural and functional repair in a mouse model of reversal of ureteral obstruction. J Am Soc Nephrol 16 (2005), 3623–3630.
6. 6 Grgic, I., Campanholle, G., Bijol, V., et al. Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis. Kidney Int 82 (2012), 172–183.
7. 7 Yang, L., Humphreys, B.D., Bonventre, J.V., Pathophysiology of acute kidney injury to chronic kidney disease: maladaptive repair. Contrib Nephrol 174 (2011), 149–155.
8. 8 Kato, H., Susztak, K., Repair problems in podocytes: Wnt, Notch, and glomerulosclerosis. Semin Nephrol 32 (2012), 350–356.
9. 9 Kang, H.M., Huang, S., Reidy, K., et al. Sox9-positive progenitor cells play a key role in renal tubule epithelial regeneration in mice. Cell Rep 14 (2016), 861–871.
10. 10 Kumar, S., Liu, J., Pang, P., et al. Sox9 activation highlights a cellular pathway of renal repair in the acutely injured mammalian kidney. Cell Rep 12 (2015), 1325–1338.
11. 11 Strutz, F., Okada, H., Lo, C.W., et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130 (1995), 393–405.
12. 12 Cornacchia, F., Fornoni, A., Plati, A.R., et al. Glomerulosclerosis is transmitted by bone marrow–derived mesangial cell progenitors. J Clin Invest 108 (2001), 1649–1656.
13. 13 Imasawa, T., Utsunomiya, Y., Kawamura, T., et al. The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J Am Soc Nephrol 12 (2001), 1401–1409.
14. 14 Ito, T., Suzuki, A., Imai, E., et al. Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J Am Soc Nephrol 12 (2001), 2625–2635.
15. 15 Ito, T., Suzuki, A., Okabe, M., et al. Application of bone marrow-derived stem cells in experimental nephrology. Exp Nephrol 9 (2001), 444–450.
16. 16 Poulsom, R., Forbes, S.J., Hodivala-Dilke, K., et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 195 (2001), 229–235.
17. 17 Bonventre, J.V., Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 14:suppl 1 (2003), S55–S61.
18. 18 Bussolati, B., Bruno, S., Grange, C., et al. Isolation of renal progenitor cells from adult human kidney. Am J Pathol 166 (2005), 545–555.
19. 19 Lazzeri, E., Crescioli, C., Ronconi, E., et al. Regenerative potential of embryonic renal multipotent progenitors in acute renal failure. J Am Soc Nephrol 18 (2007), 3128–3138.
20. 20 Angelotti, M.L., Ronconi, E., Ballerini, L., et al. Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 30 (2012), 1714–1725.
21. 21 Rabelink, T.J., Little, M.H., Stromal cells in tissue homeostasis: balancing regeneration and fibrosis. Nat Rev Nephrol 9 (2013), 747–753.
22. 22 Humphreys, B.D., Valerius, M.T., Kobayashi, A., et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2 (2008), 284–291.
23. 23 Sagrinati, C., Netti, G.S., Mazzinghi, B., et al. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol 17 (2006), 2443–2456.
24. 24 Romagnani, P., Remuzzi, G., Renal progenitors in non-diabetic and diabetic nephropathies. Trends Endocrinol Metab 24 (2013), 13–20.
25. 25 Lazzeri, E., Ronconi, E., Angelotti, M.L., et al. Human urine-derived renal progenitors for personalized modeling of genetic kidney disorders. J Am Soc Nephrol 26 (2015), 1961–1974.
26. 26 Ronconi, E., Sagrinati, C., Angelotti, M.L., et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 20 (2009), 322–332.
27. 27 Appel, D., Kershaw, D.B., Smeets, B., et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 20 (2009), 333–343.
28. 28 Rinkevich, Y., Montoro, D.T., Contreras-Trujillo, H., et al. In vivo clonal analysis reveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regeneration. Cell Rep 7 (2014), 1270–1283.
29. 29 Lasagni, L., Angelotti, M.L., Ronconi, E., et al. Podocyte regeneration driven by renal progenitors determines glomerular disease remission and can be pharmacologically enhanced. Stem Cell Reports 5 (2015), 248–263.
30. 30 Kusaba, T., Lalli, M., Kramann, R., et al. Differentiated kidney epithelial cells repair injured proximal tubule. Proc Natl Acad Sci U S A 111 (2014), 1527–1532.
31. 31 Humphreys, B.D., Czerniak, S., DiRocco, D.P., et al. Repair of injured proximal tubule does not involve specialized progenitors. Proc Natl Acad Sci U S A 108 (2011), 9226–9231.
32. 32 Smeets, B., Boor, P., Dijkman, H., et al. Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration. J Pathol 229 (2013), 645–659.
33. 33 Berger, K., Bangen, J.M., Hammerich, L., et al. Origin of regenerating tubular cells after acute kidney injury. Proc Natl Acad Sci U S A 111 (2014), 1533–1538.
34. 34 Humphreys, B.D., Lin, S.L., Kobayashi, A., et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176 (2010), 85–97.
35. 35 Kramann, R., Schneider, R.K., DiRocco, D.P., et al. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell 16 (2015), 51–66.
36. 36 Dekel, B., Shezen, E., Even-Tov-Friedman, S., et al. Transplantation of human hematopoietic stem cells into ischemic and growing kidneys suggests a role in vasculogenesis but not tubulogenesis. Stem Cells 24 (2006), 1185–1193.
37. 37 Duffield, J.S., Park, K.M., Hsiao, L.L., et al. Restoration of tubular epithelial cells during repair of the post-ischemic kidney occurs independently of bone marrow derived stem cells. J Clin Invest 115 (2005), 1743–1755.
38. 38 Friedenstein, A.J., Latzinik, N.W., Grosheva, A.G., Gorskaya, U.F., Marrow microenvironment transfer by heterotopic transplantation of freshly isolated and cultured cells in porous sponges. Exp Hematol 10 (1982), 217–227.
39. 39 Bi, B., Schmitt, R., Israilova, M., et al. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 18 (2007), 2486–2496.
40. 40 Imberti, B., Morigi, M., Tomasoni, S., et al. Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 18 (2007), 2921–2928.
41. 41 Togel, F., Hu, Z., Weiss, K., et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289 (2005), F31–F42.
42. 42 Togel, F., Cohen, A., Zhang, P., et al. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev 18 (2009), 475–485.
43. 43 da Silva Meirelles, L., Chagastelles, P.C., Nardi, N.B., Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119 (2006), 2204–2213.
44. 44 Nombela-Arrieta, C., Ritz, J., Silberstein, L.E., The elusive nature and function of mesenchymal stem cells. Nat Rev Molec Cell Biol 12 (2011), 126–131.
45. 45 Dominici, M., Le Blanc, K., Mueller, I., et al. Minimal criteria for defining multipotent mesenchymal stromal cells: The International Society for Cellular Therapy position statement. Cytotherapy 8 (2006), 315–317.
46. 46 Pittenger, M.F., Mackay, A.M., Beck, S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999), 143–147.
47. 47 Crisan, M., Yap, S., Casteilla, L., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3 (2008), 301–313.
48. 48 Horwitz, E.M., Le Blanc, K., Dominici, M., et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7 (2005), 393–395.
49. 49 Salem, H.K., Thiemermann, C., Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28 (2010), 585–596.
50. 50 Kunter, U., Rong, S., Boor, P., et al. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol 18 (2007), 1754–1764.
51. 51 Reinders, M.E., Leuning, D.G., de Fijter, J.W., et al. Mesenchymal stromal cell therapy for cardio renal disorders. Curr Pharm Des 20 (2014), 2412–2429.
52. 52 Fibbe, W.E., Nauta, A.J., Roelofs, H., Modulation of immune responses by mesenchymal stem cells. Ann New York Acad Sci 1106 (2007), 272–278.
53. 53 Nauta, A.J., Fibbe, W.E., Immunomodulatory properties of mesenchymal stromal cells. Blood 110 (2007), 3499–3506.
54. 54 Griffin, M.D., Elliman, S.J., Cahill, E., et al. Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?. Stem Cells 31 (2013), 2033–2041.
55. 55 Tan, J., Wu, W., Xu, X., et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA 307 (2012), 1169–1177.
56. 56 Pelekanos, R.A., Li, J., Gongora, M., et al. Comprehensive transcriptome and immunophenotype analysis of renal and cardiac MSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities. Stem Cell Res 8 (2012), 58–73.
57. 57 Ricardo, S.D., van Goor, H., Eddy, A.A., Macrophage diversity in renal injury and repair. J Clin Invest 118 (2008), 3522–3530.
58. 58 Wyburn, K.R., Jose, M.D., Wu, H., et al. The role of macrophages in allograft rejection. Transplantation 80 (2005), 1641–1647.
59. 59 Gordon, S., Taylor, P.R., Monocyte and macrophage heterogeneity. Nat Rev Immunol 5 (2005), 953–964.
60. 60 Kluth, D.C., Erwig, L.P., Rees, A.J., Multiple facets of macrophages in renal injury. Kidney Int 66 (2004), 542–557.
61. 61 Sean Eardley, K., Cockwell, P., Macrophages and progressive tubulointerstitial disease. Kidney Int 68 (2005), 437–455.
62. 62 Gordon, S., Alternative activation of macrophages. Nat Rev Immunol 3 (2003), 23–35.
63. 63 Sica, A., Mantovani, A., Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122 (2012), 787–795.
64. 64 Lee, S., Huen, S., Nishio, H., et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 22 (2011), 317–326.
65. 65 Ikezumi, Y., Atkins, R.C., Nikolic-Paterson, D.J., Interferon-gamma augments acute macrophage-mediated renal injury via a glucocorticoid-sensitive mechanism. J Am Soc Nephrol 14 (2003), 888–898.
66. 66 Nishida, M., Fujinaka, H., Matsusaka, T., et al. Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J Clin Invest 110 (2002), 1859–1868.
67. 67 Lopez-Guisa, J.M., Cai, X., Collins, S.J., et al. Mannose receptor 2 attenuates renal fibrosis. J Am Soc Nephrol 23 (2012), 236–251.
68. 68 Menke, J., Iwata, Y., Rabacal, W.A., et al. CSF-1 signals directly to renal tubular epithelial cells to mediate repair in mice. J Clin Invest 119 (2009), 2330–2342.
69. 69 Alikhan, M.A., Jones, C.V., Williams, T.M., et al. Colony-stimulating factor-1 promotes kidney growth and repair via alteration of macrophage responses. Am J Pathol 179 (2011), 1243–1256.
70. 70 Yokoo, T., Ohashi, T., Utsunomiya, Y., et al. Prophylaxis of antibody-induced acute glomerulonephritis with genetically modified bone marrow-derived vehicle cells. Hum Gene Ther 10 (1999), 2673–2678.
71. 71 Yamagishi, H., Yokoo, T., Imasawa, T., et al. Genetically modified bone marrow-derived vehicle cells site specifically deliver an anti-inflammatory cytokine to inflamed interstitium of obstructive nephropathy. J Immunol 166 (2001), 609–616.
72. 72 Wilson, H.M., Chettibi, S., Jobin, C., et al. Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo. Am J Pathol 167 (2005), 27–37.
73. 73 Kluth, D.C., Ainslie, C.V., Pearce, W.P., et al. Macrophages transfected with adenovirus to express IL-4 reduce inflammation in experimental glomerulonephritis. J Immunol 166 (2001), 4728–4736.
74. 74 Wilson, H.M., Stewart, K.N., Brown, P.A., et al. Bone-marrow-derived macrophages genetically modified to produce IL-10 reduce injury in experimental glomerulonephritis. Mol Ther 6 (2002), 710–717.
75. 75 Riquelme, P., Tomiuk, S., Kammler, A., et al. IFN-γ-induced iNOS expression in mouse regulatory macrophages prolongs allograft survival in fully immunocompetent recipients. Mol Ther 21 (2013), 409–422.
76. 76 Cao, Q., Wang, Y., Zheng, D., et al. IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis. J Am Soc Nephrol 21 (2010), 933–942.
77. 77 Lu, J., Cao, Q., Zheng, D., et al. Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease. Kidney Int 84 (2013), 745–755.
78. 78 Ferenbach, D.A., Ramdas, V., Spencer, N., et al. Macrophages expressing heme oxygenase-1 improve renal function in ischemia/reperfusion injury. Mol Ther 18 (2010), 1706–1713.
79. 79 Little, M.H., McMahon, A.P., Mammalian kidney development: principles, progress and projections. Cold Spring Harb Perspect Biol, 4, 2012 pii:a008300.
80. 80 Brunskill, E.W., Aronow, B.J., Georgas, K., et al. Atlas of gene expression in the developing kidney at microanatomic resolution. Dev Cell 15 (2008), 781–791.
81. 81 Brunskill, E.W., Lai, H.L., Jamison, D.C., et al. Microarrays and RNA-Seq identify molecular mechanisms driving the end of nephron production. BMC Dev Biol, 11, 2011, 15.
82. 82 Park, J.S., Ma, W., O'Brien, L.L., et al. Six2 and Wnt regulate self-renewal and commitment of nephron progenitors through shared gene regulatory networks. Dev Cell 23 (2012), 637–651.
83. 83 Takasato, M., Little, M.H., The origin of the mammalian kidney: implications for recreating the kidney in vitro. Development 142 (2015), 1937–1947.
84. 84 Brown, A.C., Muthukrishnan, S.D., Oxburgh, L., A synthetic niche for nephron progenitor cells. Dev Cell 34 (2015), 229–241.
85. 85 Dekel, B., Amariglio, N., Kaminski, N., et al. Engraftment and differentiation of human metanephroi into functional mature nephrons after transplantation into mice is accompanied by a profile of gene expression similar to normal human kidney development. J Am Soc Nephrol 13 (2002), 977–990.
86. 86 Dekel, B., Burakova, T., Arditti, F.D., et al. Human and porcine early kidney precursors as a new source for transplantation. Nat Med 9 (2003), 53–60.
87. 87 Rogers, S.A., Hammerman, M.R., Transplantation of rat metanephroi into mice. Am J Physiol Regul Integr Comp Physiol 280 (2001), R1865–R1869.
88. 88 Pode-Shakked, N., Metsuyanim, S., Rom-Gross, E., et al. Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population. J Cell Mol Med 13 (2009), 1792–1808.
89. 89 Metsuyanim, S., Harari-Steinberg, O., Buzhor, E., et al. Expression of stem cell markers in the human fetal kidney. PloS One, 4, 2009, e6709.
90. 90 Pode-Shakked, N., Dekel, B., Wilms tumor—a renal stem cell malignancy?. Pediatr Nephrol 26 (2011), 1535–1543.
91. 91 Harari-Steinberg, O., Metsuyanim, S., Omer, D., et al. Identification of human nephron progenitors capable of generation of kidney structures and functional repair of chronic renal disease. EMBO Mol Med 5 (2013), 1556–1568.
92. 92 Perin, L., Sedrakyan, S., Da Sacco, S., De Filippo, R., Characterization of human amniotic fluid stem cells and their pluripotential capability. Methods Cell Biol 86 (2008), 85–99.
93. 93 Perin, L., Giuliani, S., Jin, D., et al. Renal differentiation of amniotic fluid stem cells. Cell Prolif 40 (2007), 936–948.
94. 94 Sedrakyan, S., Da Sacco, S., Milanesi, A., et al. Injection of amniotic fluid stem cells delays progression of renal fibrosis. J Am Soc Nephrol 23 (2012), 661–673.
95. 95 Da Sacco, S., Lemley, K.V., Sedrakyan, S., et al. A novel source of cultured podocytes. PLoS One, 8, 2013, e81812.
96. 96 Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006), 663–676.
97. 97 Takahashi, K., Tanebe, K., Ohnuki, M., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007), 861–872.
98. 98 Hotta, A., Yamanaka, S., From genomics to gene therapy: induced pluripotent stem cells meet genome editing. Annu Rev Genet 49 (2015), 47–70.
99. 99 Mae, S., Shono, A., Shiota, F., et al. Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells. Nat Commun, 4, 2013, 1367.
100. 100 Lam, A.Q., Freedman, B.S., Morizane, R., et al. Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. J Am Soc Nephrol 25 (2014), 1211–1225.
101. 101 Xia, Y., Nivet, E., Sancho-Martinez, I., et al. Directed differentiation of human pluripotent cells to ureteric bud kidney progenitor-like cells. Nat Cell Biol 15 (2013), 1507–1515.
102. 102 Taguchi, A., Kaku, Y., Ohmori, T., et al. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell 14 (2014), 53–67.
103. 103 Sharmin S, Taguchi A, Kaku Y, et al. Human induced pluripotent stem cell-derived podocytes mature into vascularized glomeruli upon experimental transplantation [e-pub ahead of print]. J Am Soc Nephrol. http://dx.doi.org/10.1681/ASN.2015010096, Accessed April 21, 2016.
104. 104 Morizane, R., Lam, A.Q., Freedman, B.S., et al. Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat Biotechnol 33 (2015), 1193–1200.
105. 105 Freedman, B.S., Brooks, C.R., Lam, A.Q., et al. Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat Commun, 6, 2015, 8715.
106. 106 Takasato, M., Er, P.X., Becroft, M., et al. Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney. Nat Cell Biol 16 (2014), 118–126.
107. 107 Unbekandt, M., Davies, J.A., Dissociation of embryonic kidneys followed by reaggregation allows the formation of renal tissues. Kidney Int 77 (2010), 407–416.
108. 108 Lusis, M., Li, J., Ineson, J., et al. Isolation of clonogenic, long-term self renewing embryonic renal stem cells. Stem Cell Res 5 (2010), 23–39.
109. 109 Takasato, M., Er, P.X., Chiu, H.S., et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 526 (2015), 564–568.
110. 110 Takebe, T., Sekine, K., Enomura, M., et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499 (2013), 481–484.
111. 111 Takebe, T., Enomura, M., Yoshizawa, E., et al. Vascularized and complex organ buds from diverse tissues via mesenchymal cell-driven condensation. Cell Stem Cell 16 (2015), 556–565.
112. 112 Song, B., Smink, A.M., Jones, C.V., et al. The directed differentiation of human iPS cells into kidney podocytes. PLoS One, 7, 2012, e46453.
113. 113 Narayanan, K., Schumacher, K.M., Tasnim, F., et al. Human embryonic stem cells differentiate into functional renal proximal tubular-like cells. Kidney Int 83 (2013), 593–603.
114. 114 Li, Y., Kandasamy, K., Chuah, J.K., et al. Identification of nephrotoxic compounds with embryonic stem-cell-derived human renal proximal tubular-like cells. Mol Pharm 11 (2014), 1982–1990.
115. 115 Toyohara, T., Mae, S., Sueta, S., et al. Cell therapy using human induced pluripotent stem cell-derived renal progenitors ameliorates acute kidney injury in mice. Stem Cells Transl Med 4 (2015), 980–992.
116. 116 Imberti, B., Tomasoni, S., Ciampi, O., et al. Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury. Sci Rep, 5, 2015, 8826.
117. 117 Davis, R.L., Weintraub, H., Lassar, A.B., Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51 (1987), 987–1000.
118. 118 Vanslambrouck, J.M., Little, M.H., Direct transcriptional reprogramming to nephron progenitors. Curr Opin Genet Dev 34 (2015), 10–16.
119. 119 Hendry, C.E., Vanslambrouck, J.M., Ineson, J., et al. Direct transcriptional reprogramming of adult cells to embryonic nephron progenitors. J Am Soc Nephrol 24 (2013), 1424–1434.